CFO
ATNM icon

Callan Family Office’s Actinium Pharmaceuticals ATNM Stock Holding History

Callan Family Office’s Portfolio ATNM Stock Details ATNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$33K Hold
23,603
– – ﹤0.01% 904
2025
Q1 		$38K Buy
+23,603
New +$38K ﹤0.01% 541